Hypertrophic Cardiomyopathy
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
|
1645238 |
1991 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
|
7504405 |
1993 |
Hypertrophic Cardiomyopathy
|
0.200 |
GeneticVariation
|
disease |
CLINVAR |
Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease.
|
7575533 |
1995 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.
|
7911050 |
1994 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Mutation analysis in patients with the typical form of Anderson-Fabry disease.
|
8395937 |
1993 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.
|
10666480 |
1999 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.
|
11828341 |
2002 |
Hypertrophic Cardiomyopathy
|
0.200 |
GeneticVariation
|
disease |
CLINVAR |
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
|
11914245 |
2002 |
Hypertrophic Cardiomyopathy
|
0.200 |
Biomarker
|
disease |
BEFREE |
Plasma alpha-galactosidase A (alpha-Gal) was measured in 79 men with HCM who were diagnosed at > or =40 years of age (52.9+/-7.7 years; range, 40-71 years) and in 74 men who were diagnosed at <40 years (25.9+/-9.2 years; range, 8-39 years).
|
11914245 |
2002 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease.
|
15702404 |
2005 |
Hypertrophic Cardiomyopathy
|
0.200 |
GeneticVariation
|
disease |
CLINVAR |
Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.
|
17555407 |
2007 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.
|
17555407 |
2007 |
Hypertrophic Cardiomyopathy
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
We screened the plasma alpha-galactosidase A activity from 508 unrelated patients with HCM (328 men, 180 women, ages 58 +/- 16 years).
|
18154965 |
2007 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).
|
19621417 |
2009 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Transposable elements in disease-associated cryptic exons.
|
19823873 |
2010 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.
|
20031620 |
2009 |
Hypertrophic Cardiomyopathy
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Fabry disease, an X-linked storage disorder caused by defective lysosomal enzyme alpha-galactosidase A activity, may resemble sarcomere-gene-associated hypertrophic cardiomyopathy (HCM).
|
20498269 |
2010 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).
|
20821055 |
2010 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease.
|
21598360 |
2011 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).
|
21972175 |
2012 |
Hypertrophic Cardiomyopathy
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Fabry disease is an X-linked lysosomal storage disorder caused by mutations of the α-galactosidase A gene (GLA), and the disease is a relatively prevalent cause of left ventricular hypertrophy mimicking idiopathic hypertrophic cardiomyopathy.
|
22008442 |
2011 |
Hypertrophic Cardiomyopathy
|
0.200 |
Biomarker
|
disease |
BEFREE |
This case highlights diagnostic dilemmas that can be provoked by VUS in general, and specifically raises a question whether GLA sequencing should be included in first-line diagnostic testing for female children with isolated hypertrophic cardiomyopathy.
|
22336178 |
2012 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations.
|
22437327 |
2012 |
Hypertrophic Cardiomyopathy
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation.
|
23109060 |
2013 |